Squarepoint’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $217K | Sell |
4,159
-55,510
| -93% | -$3.33M | ﹤0.01% | 3916 |
|
|
2025
Q4 | $3.51M | Sell |
59,669
-124,437
| -68% | -$7.56M | ﹤0.01% | 1687 |
|
|
2025
Q3 | $10.2M | Sell |
184,106
-308,786
| -63% | -$16.5M | 0.01% | 1060 |
|
|
2025
Q2 | $25.4M | Buy |
492,892
+483,440
| +5,115% | +$24.3M | 0.03% | 653 |
|
|
2025
Q1 | $554K | Buy |
9,452
+392
| +4% | +$26.6K | ﹤0.01% | 3198 |
|
|
2024
Q4 | $653K | Buy |
9,060
+4,816
| +113% | +$354K | ﹤0.01% | 3482 |
|
|
2024
Q3 | $339K | Sell |
4,244
-28,090
| -87% | -$2.11M | ﹤0.01% | 3367 |
|
|
2024
Q2 | $2.32M | Buy |
32,334
+15,345
| +90% | +$1.13M | ﹤0.01% | 1941 |
|
|
2024
Q1 | $1.2M | Buy |
16,989
+12,704
| +296% | +$909K | ﹤0.01% | 2463 |
|
|
2023
Q4 | $331K | Sell |
4,285
-82,621
| -95% | -$5.44M | ﹤0.01% | 3290 |
|
|
2023
Q3 | $5.92M | Buy |
86,906
+80,873
| +1,341% | +$6.39M | 0.01% | 1070 |
|
|
2023
Q2 | $492K | Sell |
6,033
-182,532
| -97% | -$14.7M | ﹤0.01% | 2630 |
|
|
2023
Q1 | $14M | Buy |
188,565
+126,550
| +204% | +$9.75M | 0.06% | 408 |
|
|
2022
Q4 | $5.14M | Buy |
62,015
+45,975
| +287% | +$3.65M | 0.02% | 830 |
|
|
2022
Q3 | $1.14M | Buy |
+16,040
| New | +$1.39M | 0.01% | 1680 |
|
|
2022
Q1 | – | Sell |
-53,332
| Closed | -$6.9M | – | 3506 |
|
|
2021
Q4 | $6.9M | Buy |
53,332
+11,176
| +27% | +$1.37M | 0.02% | 665 |
|
|
2021
Q3 | $5.11M | Buy |
+42,156
| New | +$5.13M | 0.01% | 770 |
|
|
2021
Q1 | – | Sell |
-16,428
| Closed | -$1.3M | – | 3605 |
|
|
2020
Q4 | $1.3M | Sell |
16,428
-17,192
| -51% | -$1.25M | 0.01% | 1170 |
|
|
2020
Q3 | $2.08M | Buy |
+33,620
| New | +$2.19M | 0.03% | 639 |
|
|
2020
Q2 | – | Sell |
-35,156
| Closed | -$1.67M | – | 2510 |
|
|
2020
Q1 | $1.67M | Sell |
35,156
-41,380
| -54% | -$2.07M | 0.04% | 508 |
|
|
2019
Q4 | $4.2M | Buy |
76,536
+44,624
| +140% | +$2.34M | 0.03% | 563 |
|
|
2019
Q3 | $1.56M | Sell |
31,912
-60,092
| -65% | -$3.01M | 0.01% | 962 |
|
|
2019
Q2 | $4.79M | Buy |
92,004
+74,500
| +426% | +$3.75M | 0.05% | 454 |
|
|
2019
Q1 | $869K | Buy |
17,504
+7,856
| +81% | +$354K | 0.01% | 1176 |
|
|
2018
Q4 | $349K | Sell |
9,648
-6,964
| -42% | -$291K | ﹤0.01% | 1428 |
|
|
2018
Q3 | $848K | Buy |
16,612
+4,608
| +38% | +$204K | 0.01% | 1071 |
|
|
2018
Q2 | $444K | Sell |
12,004
-48,568
| -80% | -$1.85M | 0.01% | 1229 |
|
|
2018
Q1 | $2.29M | Buy |
60,572
+51,308
| +554% | +$1.81M | 0.04% | 522 |
|
|
2017
Q4 | $300K | Buy |
+9,264
| New | +$294K | 0.01% | 1510 |
|
Other funds holding TECH
VCM
VPM
MC
Squarepoint's TECH Position: Q1 2026 in Review
Squarepoint reduced its Bio-Techne (TECH) stake by 93% in Q1 2026, selling an estimated $3.33M and leaving 4,159 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #3916.
Squarepoint first reported a position in TECH in Q4 2017 and has held it in 29 quarters since. The position peaked at $25.4M in Q2 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Squarepoint held 4,159 shares of Bio-Techne worth $217K as of Q1 2026.
- Squarepoint sold 55,510 Bio-Techne shares in Q1 2026, an estimated $3.33M.
- Bio-Techne made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3916 holding.
- Squarepoint first reported a position in Bio-Techne in Q4 2017 and has held it in 29 quarters since.
- Squarepoint's Bio-Techne position peaked at $25.4M in Q2 2025.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.